215 related articles for article (PubMed ID: 7905518)
21. Effect of opioid peptides on circular muscle of canine duodenum.
Bauer AJ; Szurszewski JH
J Physiol; 1991 Mar; 434():409-22. PubMed ID: 1673718
[TBL] [Abstract][Full Text] [Related]
22. Opioid actions on neurons of rat lateral amygdala in vitro.
Sugita S; North RA
Brain Res; 1993 May; 612(1-2):151-5. PubMed ID: 8101129
[TBL] [Abstract][Full Text] [Related]
23. Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons.
Moises HC; Rusin KI; Macdonald RL
J Neurosci; 1994 Oct; 14(10):5903-16. PubMed ID: 7931552
[TBL] [Abstract][Full Text] [Related]
24. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.
Jin W; Lee NM; Loh HH; Thayer SA
Mol Pharmacol; 1992 Dec; 42(6):1083-9. PubMed ID: 1336113
[TBL] [Abstract][Full Text] [Related]
25. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
26. Characterization of opioid-sensitive neurons in the anteroventral third ventricle region of polydipsic inbred mice in vitro.
Hattori Y; Katafuchi T; Koizumi K
Brain Res; 1991 Jan; 538(2):283-8. PubMed ID: 1672830
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of opioid effects in the rat hippocampal slice.
Valentino RJ; Dingledine R
J Pharmacol Exp Ther; 1982 Nov; 223(2):502-9. PubMed ID: 6752374
[TBL] [Abstract][Full Text] [Related]
28. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
Müller W; Hallermann S; Swandulla D
J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of exocrine pancreatic secretion by opiates is mediated by suppression of cholinergic transmission: characterization of receptor subtypes.
Louie DS; Chen HT; Owyang C
J Pharmacol Exp Ther; 1988 Jul; 246(1):132-6. PubMed ID: 2455787
[TBL] [Abstract][Full Text] [Related]
30. Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes.
Gannon RL; Terrian DM
Neurochem Res; 1992 Aug; 17(8):741-7. PubMed ID: 1353613
[TBL] [Abstract][Full Text] [Related]
31. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons.
Ventura C; Spurgeon H; Lakatta EG; Guarnieri C; Capogrossi MC
Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro.
Lupica CR; Proctor WR; Dunwiddie TV
Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320
[TBL] [Abstract][Full Text] [Related]
33. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices.
Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M
Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485
[TBL] [Abstract][Full Text] [Related]
34. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
Dunwiddie TV; Johnson KJ; Proctor WR
Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
[TBL] [Abstract][Full Text] [Related]
35. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
36. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
Tiseo PJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cardiovascular responses to intra-hippocampal mu, delta and kappa opioid agonists in spontaneously hypertensive rats and isolation-induced hypertensive rats.
Shen S; Ingenito AJ
J Hypertens; 1999 Apr; 17(4):497-505. PubMed ID: 10404951
[TBL] [Abstract][Full Text] [Related]
38. Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
Alzheimer C; ten Bruggencate G
J Pharmacol Exp Ther; 1990 Nov; 255(2):900-5. PubMed ID: 1978733
[TBL] [Abstract][Full Text] [Related]
39. Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro.
Inenaga K; Nagatomo T; Nakao K; Yanaihara N; Yamashita H
Neuroscience; 1994 Jan; 58(2):331-40. PubMed ID: 7908725
[TBL] [Abstract][Full Text] [Related]
40. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
Chavkin C; Henriksen SJ; Siggins GR; Bloom FE
Brain Res; 1985 Apr; 331(2):366-70. PubMed ID: 2859095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
